These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4692028)

  • 1. The kinetics of human interferon clearance in gibbons.
    Skreko F; Zajac I; Bahnsen HP; Haff RF; Cantell K
    Proc Soc Exp Biol Med; 1973 Mar; 142(3):946-7. PubMed ID: 4692028
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating interferon in rabbits after administration of human interferon by different routes.
    Cantell K; Pyhälä L
    J Gen Virol; 1973 Jul; 20(1):97-104. PubMed ID: 4356685
    [No Abstract]   [Full Text] [Related]  

  • 3. No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits.
    Mogensen KE; Pyhälä L; Törmä E; Cantell K
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Jun; 82(3):305-10. PubMed ID: 4368958
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits.
    Edy VG; Billiau A; De Somer P
    J Infect Dis; 1976 Jun; 133 Suppl():A18-21. PubMed ID: 932502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of human leukocyte interferon.
    Cantell K; Pyhälä L
    J Infect Dis; 1976 Jun; 133 Suppl():A6-12. PubMed ID: 932506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance of human interferon in rabbits induced to make rabbit interferon.
    Pyhala L; Cantell K
    Proc Soc Exp Biol Med; 1974 Jun; 146(2):394-7. PubMed ID: 4834448
    [No Abstract]   [Full Text] [Related]  

  • 7. [Distribution of human interferon in organs and tissues after its administration to man and animals].
    Maiakova SA; Berulava II; Gavrilova IE; Kuznetsov VP
    Vopr Virusol; 1980; (5):594-6. PubMed ID: 6159738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating interferon in man after administration of exogenous human leukocyte interferon.
    Emödi G; Just M; Hernandez R; Hirt HR
    J Natl Cancer Inst; 1975 May; 54(5):1045-9. PubMed ID: 1127735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon clearance rate decreased after repeated injections.
    Nuwer MR; De Clercq E; Merigan TC
    J Gen Virol; 1971 Aug; 12(2):191-4. PubMed ID: 4330791
    [No Abstract]   [Full Text] [Related]  

  • 10. [Stimulation of interferon formation in animals and humans and the obtainment of donor plasma containing interferon for clinical parenteral use].
    Skurkovich SV; Sabashvili MK
    Probl Gematol Pereliv Krovi; 1971 Jun; 16(6):11-4. PubMed ID: 5119056
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of vaccinia lesions in Rhesus monkeys by human leucocyte and fibroblast interferon.
    Weimar W; Stitz L; Billiau A; Cantell K; Schellekens H
    J Gen Virol; 1980 May; 48(1):25-30. PubMed ID: 6155433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary observations on the effect of human leukocyte interferon in non-Hodgkin's lymphoma.
    Merigan TC; Sikora K; Breeden JH; Levy R; Rosenberg SA
    N Engl J Med; 1978 Dec; 299(26):1449-53. PubMed ID: 362211
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-appearance of injected fibroblast interferon in circulation.
    Edy VG; Billiau A; De Somer P
    Lancet; 1978 Feb; 1(8061):451-2. PubMed ID: 75485
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmacokinetics of human interferons].
    Furue H; Kobayashi H; Komuro T; Kako M; Mugitani H; Fuse K; Kaise R; Nagai K; Takahashi T; Hirota F
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):935-42. PubMed ID: 6721508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of routes of administration of interferon in cancer: a review and a proposal.
    Bocci V
    Cancer Drug Deliv; 1984; 1(4):337-51. PubMed ID: 6085757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interim report on studies on "toxic" effects of human leucocyte-derived interferon-alpha (HuIFN-alpha).
    Scott GM; Wallace J; Tyrrell DA; Cantell K; Secher DS; Stewart WE
    J Interferon Res; 1982; 2(1):127-30. PubMed ID: 6180101
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of a human interferon preparation on vaccine-induced rubella infection.
    Best JM; Banatvala JE
    J Biol Stand; 1975; 3(1):107-12. PubMed ID: 1126957
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon in the treatment of ovarian cancer.
    Welander CE
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):26-9. PubMed ID: 2461594
    [No Abstract]   [Full Text] [Related]  

  • 19. Production and purification of human leukocyte interferon.
    Matsuo A; Hayashi S; Kishida T
    Jpn J Microbiol; 1974 Jan; 18(1):21-7. PubMed ID: 4546893
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating human interferon after intramuscular injection into animals and man.
    Cantell K; Pyhälä L; Strander H
    J Gen Virol; 1974 Dec; 25(3):453-5. PubMed ID: 4443796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.